This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Thu May 23, 2013 4:38 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 1 post ] 
Author Message
 Post subject: St Jude study
PostPosted: Wed Jan 24, 2007 8:56 pm 
Offline
Family Elder
User avatar

Joined: Sat Feb 18, 2006 4:00 pm
Posts: 516
Location: suburb of Chicago, IL USA
Chopping Off Protein Puts Immune Cells Into High Gear


St. Jude study shows LAG-3 protein on activated T lymphocytes slows replication until ADAM10 and ADAM17 enzymes cleave it off to allow these cells to reproduce rapidly

MEMPHIS, Tenn., Jan. 24 /PRNewswire/ -- The complex task of launching a well-organized, effective immune system attack on specific targets is thrown into high gear when either of two specific enzymes chop a protein called LAG-3 off the immune cells leading that battle, according to investigators at St. Jude Children's Research Hospital.

These cells, called T lymphocytes, are key to the body's ability to fight off infections, tailoring the immune response so it focuses on specific targets. When activated, certain T lymphocytes called effector T cells reproduce, increasing their numbers and enhancing their ability to protect the body.

The St. Jude finding is important because it represents a new concept in how T cells are regulated, according to Dario Vignali, Ph.D., associate member of the St. Jude Department of Immunology. The study offers the first example of a protein that is required for dampening T cell activity being controlled by getting chopped off at the T cell's surface, he said.

The team demonstrated that LAG-3 is cleaved by two metalloprotease enzymes, called ADAM10 and ADAM17. The activity of these enzymes is under controlled by distinct but overlapping signals generated from the T cell receptor, a specialized protein that allows T lymphocytes to "see" the outside world. In either case, when metalloproteases remove LAG-3, the brakes are taken off T cell activity. Certain drugs that inhibit metalloproteases now under development as treatments for multiple sclerosis and arthritis appear to work by keeping T cells on a tight leash, Vignali noted. The new discovery could demonstrate an additional way in which these drugs work. Vignali is senior author of a report on this work that appears in the January 24 issue of The EMBO Journal.


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Anyone out there in this Study???

fightingms

2

1851

Mon Mar 08, 2004 6:55 am

fightingms View the latest post

There are no new unread posts for this topic. I'm In the Study

[ Go to pageGo to page: 1, 2 ]

fightingms

19

5064

Sun May 16, 2004 3:18 pm

2gentle View the latest post

There are no new unread posts for this topic. Another study on possible causes

bromley

1

1099

Wed Nov 23, 2005 6:18 am

Melody View the latest post

There are no new unread posts for this topic. new study

jimmylegs

2

940

Mon May 15, 2006 12:01 pm

jimmylegs View the latest post

There are no new unread posts for this topic. minocycline study for MS

arthurherr

2

1455

Thu Jan 06, 2005 9:05 am

HappyDaddy View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: